Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting System
{{output}}
Purpose: Predicting severe adverse events (SAEs) in oncology is challenging because of complex therapies and patient heterogeneity. Traditional pharmacovigilance methods often fail to capture multifactorial risk patterns. Machine... ...
